Tanisha Nayak, Nibedita Dixit, Anil K Panda, Maitreyee Panda
{"title":"Efficacy and Safety of Injection Secukinumab in Patients of Pediatric Erythrodermic Psoriasis.","authors":"Tanisha Nayak, Nibedita Dixit, Anil K Panda, Maitreyee Panda","doi":"10.4103/idoj.idoj_388_25","DOIUrl":"10.4103/idoj.idoj_388_25","url":null,"abstract":"","PeriodicalId":13335,"journal":{"name":"Indian Dermatology Online Journal","volume":" ","pages":"705-707"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13588460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147473553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zeinab Abu El Baha Gouda, Hanan A Assaf, Noha Saber Shafik Amin, Reham Helal Abu Elhamd, Mohammed Abu El-Hamd
{"title":"Gene Expression of Suppressor of Cytokine Signaling 3 (SOCS3), Interferons Alpha and Beta (IFN-α and β) in Common Warts.","authors":"Zeinab Abu El Baha Gouda, Hanan A Assaf, Noha Saber Shafik Amin, Reham Helal Abu Elhamd, Mohammed Abu El-Hamd","doi":"10.4103/idoj.idoj_893_25","DOIUrl":"10.4103/idoj.idoj_893_25","url":null,"abstract":"<p><strong>Background: </strong>Cutaneous warts are benign epidermal growths caused by low-risk human papillomavirus. Interferon promotes an \"antiviral state\" in infected cells and neighboring cells through the activation of interferon-stimulated genes. The suppressor of cytokine signaling (SOCS) proteins bind to both Janus kinase and tyrosine kinase receptors, which further inhibit signal transducer and activator of transcription 3 phosphorylation.</p><p><strong>Aim and objectives: </strong>This study aimed to assess the tissue gene expression of SOCS3 and interferons alpha and beta ( IFN-α and β ) in common warts.</p><p><strong>Patients and methods: </strong>Forty patients with common warts, aged between 18 and 50 years, and 40 healthy controls were recruited. The gene expression of IFN-α, IFN-β, and SOCS3 by real-time reverse transcription polymerase chain reaction in the skin biopsies from the warts, normal skin of the patients, and healthy controls was estimated.</p><p><strong>Results: </strong>The median level of IFN-α was significantly higher in warts than non-lesional skin (20.8 vs 1) and both were significantly higher than that of control skin (0.7). The median level of IFN-β was significantly higher in warts than in non-lesional skin (20.7 vs 1.4) and both were significantly higher than that of control skin (1). The median level of SOCS3 was higher in nonlesional skin than in warts (1.05 vs 1), and both were significantly higher than that of control skin (0.1).</p><p><strong>Limitations: </strong>Small sample size.</p><p><strong>Conclusion: </strong>The expressions of IFN-α, IFN-β, and SOCS3 genes were significantly elevated in the lesional and nonlesional skin of patients with warts than in the control skin.</p>","PeriodicalId":13335,"journal":{"name":"Indian Dermatology Online Journal","volume":" ","pages":"668-674"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13588442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148827895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Assessment of Serum Survivin Levels as a Potential Biomarker for Disease Severity and Therapeutic Outcome: Results of a Pilot Study.","authors":"Kuruva Janakiramudu, Sumita Halder, Rajarshi Kar, Chander Grover, Rachna Gupta, Edelburt A Almeida","doi":"10.4103/idoj.idoj_1122_25","DOIUrl":"10.4103/idoj.idoj_1122_25","url":null,"abstract":"<p><strong>Background: </strong>Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferation of keratinocytes and immune dysregulation. Survivin, being an apoptosis inhibitor, could be a potential biomarker for psoriasis.</p><p><strong>Aim and objectives: </strong>To evaluate serum survivin levels in moderate to severe psoriasis patients before and after methotrexate therapy and to assess its correlation with disease severity using Psoriasis Area and Severity Index (PASI).</p><p><strong>Patients and methods: </strong>This study included 30 patients with moderate to severe psoriasis and 30 healthy controls. Serum survivin levels were measured at baseline and at 12 weeks of methotrexate therapy. Disease severity was assessed using PASI.</p><p><strong>Results: </strong>Serum survivin levels were considerably higher in psoriasis patients than in controls (70.3 ± 16.9 vs. 22.1 ± 9.4 pg/mL; P < 0.001). Following methotrexate therapy, serum survivin levels decreased (20.9 ± 8.0 pg/mL; P < 0.001) and PASI scores reduced in tandem from 15.3 ± 4.8 to 7.5 ± 4.4 ( P < 0.001). Improvement in PASI was significantly associated with survivin reduction (r = 0.672; P < 0.001).</p><p><strong>Limitations: </strong>Small sample size, short follow-up duration, and lack of histopathological assessment or tissue survivin evaluation. Additionally, the absence of long-term follow-up and potential noncompliance with smoking/alcohol abstinence may have influenced the findings.</p><p><strong>Conclusion: </strong>Serum survivin levels were significantly elevated in psoriasis patients compared to healthy controls and were reduced significantly following treatment with methotrexate. These changes in serum survivin levels corresponded well with decreasing PASI scores in psoriasis patients, suggesting survivin as a potential biomarker of disease activity and therapeutic response.</p>","PeriodicalId":13335,"journal":{"name":"Indian Dermatology Online Journal","volume":"17 5","pages":"688-692"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13588454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148863853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Pink Dome on the Digit: Diagnostic Clues to a Digital Myxoid Cyst.","authors":"Chitwan Kaur Ghuman, Veeranna Shastry","doi":"10.4103/idoj.idoj_1042_25","DOIUrl":"10.4103/idoj.idoj_1042_25","url":null,"abstract":"","PeriodicalId":13335,"journal":{"name":"Indian Dermatology Online Journal","volume":" ","pages":"760-761"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13588444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148163127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}